Talk:90Y-Ibritumomab Tiuxetan: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Howard C. Berkowitz
(Talk page generated using Special:MetadataForm)
 
imported>Howard C. Berkowitz
Line 1: Line 1:
{{subpages}}
{{subpages}}
== Did  some formatting ==
Hi Kelsy,
Interesting article. I essentially did some formatting to CZ style, but didn't change content. You'll see that I redid the first reference so it appears as a footnote.  I did remove one reference to a Wikipedia article, which we don't use as a source. Let me know if I can help with the references.
[[User:Howard C. Berkowitz|Howard C. Berkowitz]] 12:36, 1 November 2010 (UTC)

Revision as of 06:36, 1 November 2010

This article is developing and not approved.
 Main Article
 Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
To learn how to update the categories for this article, see here. To update categories, edit the metadata template.
 Definition:  An antineoplastic agent that uses a monoclonal antibody to deliver radioisotopes to cancer cells [d] [e]
Checklist and Archives
 Workgroup category:  Health Sciences [Editors asked to check categories]
 Talk Archive:  none  English language variant:  British English

Did some formatting

Hi Kelsy,

Interesting article. I essentially did some formatting to CZ style, but didn't change content. You'll see that I redid the first reference so it appears as a footnote. I did remove one reference to a Wikipedia article, which we don't use as a source. Let me know if I can help with the references.

Howard C. Berkowitz 12:36, 1 November 2010 (UTC)

Retrieved from "https://citizendium.org/wiki/index.php?title=Talk:90Y-Ibritumomab_Tiuxetan&oldid=810033"